Will there be a role for neuroimaging in clinical psychiatry?

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 5, 2010, Pages 291-293

  Macqueen, Glenda M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMETHASONE;

ALZHEIMER DISEASE; ANXIETY DISORDER; ARTICLE; AUTISM; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL PRACTICE; COGNITIVE THERAPY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; FRONTOTEMPORAL DEMENTIA; GENETIC VARIABILITY; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; METABOLOMICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOGENETICS; PROTEOMICS; PSYCHIATRY; PSYCHOSIS; SCHIZOPHRENIA; SUPPORT VECTOR MACHINE; TREATMENT RESPONSE;

EID: 77956515644     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: 10.1503/jpn.100129     Document Type: Editorial

References (20)

1. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry 2009;66:128-33.
2. Fu CH, Mourao-Miranda J, Costafreda SG, et al. Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry 2008;63:656-62.
3. Nouretdinov I, Costafreda SG, Gammerman A, et al Machine learning classification with confidence: Application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression. Neuroimage 2010 May 17 [Epub ahead of print].
4. Ecker C, Rocha-Rego V, Johnston P, et al.; MRC AIMS Consortium. Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach. Neuroimage 2010;49:44-56.
5. Klöppel S, Stonnington CM, Barnes J, et al. Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 2008;131:2969-74.
6. Frodl T, Jager M, Smajstrlov I, et al. Effect of hippocampal and amygdale volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 2008;33:423-30.
7. MacQueen GM, Yucel K, Taylor VH, et al. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry 2008;64:880-3.
8. Hsieh MH, McQuoid DR, Levy RM, et al. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry 2002;17:519-25.
9. Kronmüller KT, Pantel J, Köhler S, et al. Hippocampal volume and two year outcome in depression. Br J Psychiatry 2008;192:472-3.
10. McKinnon MC, Yucel K, Nazarov A, et al. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:41-54.
11. Bryant RA, Felmingham K, Kemp A, et al. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med 2008;38:555-61.
12. Nitschke JB, Sarinopoulos I, Oathes DJ, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009; 166:302-10.
13. Fu CH, Williams SC, Cleare AJ, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008;64:505-12.
14. Canli T, Cooney RE, Goldin P, et al. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 2005;16:1267-70.
15. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008;9:788-96.
16. Brammer M. The role of neuroimaging in diagnosis and personalized medicine - current position and likely future directions. Dialogues Clin Neurosci 2009;11:389-96.
17. Eack SM, Hogarty GE, Cho RY, et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 2010;67:674-82.
18. Ciumas C, Montavont A, Ryvlin P. Magnetic resonance imaging in clinical trials. Curr Opin Neurol 2008;21:431-6.
19. Downing GJ. Policy perspectives on the emerging pathways of personalized medicine. Dialogues Clin Neurosci 2009;11:377-87.
20. Bullmore E, Fletcher P, Jones PB. Why psychiatry can't afford to be neurophobic. Br J Psychiatry 2009;194:293-5.